Biotechnology
The Biotechnology industry has a total of 606 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.47 billion.
Market Cap
1.11T
Revenue
105.47B
Profits
-42.14B
PE Ratio
n/a
Profit Margin
-39.96%
Dividend Yield
0.04%
605 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.03B | -0.08% | 660,272 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.19B | -0.27% | 355,121 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 52.54B | 0.10% | 768,618 | 3.21B |
| 4 | ARGX | argenx SE | 51.51B | 0.36% | 110,253 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.12B | -0.03% | 1,777,772 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 33.62B | -0.30% | 187,867 | 4.97B |
| 7 | BNTX | BioNTech SE | 22.89B | -0.08% | 446,726 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.30B | -0.90% | 2,332,395 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.67B | -2.19% | 1,940,953 | 3.85B |
| 10 | INCY | Incyte Corporation | 19.39B | -0.14% | 1,358,782 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.40B | -0.03% | 830,243 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 15.09B | 0.32% | 5,593,901 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.74B | 1.34% | 1,217,956 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.49B | - | 1,643,997 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.23B | -0.24% | 153,987 | 740.64M |
| 16 | ASND | Ascendis Pharma A/S | 13.03B | 1.86% | 460,354 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.81B | 0.18% | 1,090,955 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.80B | -0.48% | 1,756,944 | 2.29B |
| 19 | MRNA | Moderna, Inc. | 11.52B | -3.03% | 8,946,889 | 2.23B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.42B | 0.75% | 1,360,488 | 3.09B |
| 21 | ABVX | ABIVAX Société Anonyme | 11.00B | -2.52% | 2,756,842 | 6.23M |
| 22 | RNA | Avidity Biosciences, Inc. | 10.87B | -0.03% | 1,179,319 | 20.87M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.33B | -0.48% | 323,170 | 4.16B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.21B | 22.75% | 3,059,410 | 561.26M |
| 25 | TECH | Bio-Techne Corporation | 9.16B | -0.52% | 840,388 | 1.22B |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.02B | -1.28% | 1,066,512 | 829.45M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 7.91B | -0.59% | 977,242 | 1.24B |
| 28 | NUVL | Nuvalent, Inc. | 7.81B | 0.21% | 374,091 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 7.77B | 3.54% | 1,911,826 | 87.21M |
| 30 | CAI | Caris Life Sciences, Inc. | 7.61B | -1.24% | 1,590,155 | 649.06M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.37B | -0.77% | 515,148 | 7.46M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.15B | -0.54% | 192,822 | 373.16M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.14B | 0.26% | 481,427 | 174.33M |
| 34 | CDTX | Cidara Therapeutics, Inc. | 6.96B | 0.04% | 507,798 | 302.00K |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.22B | -0.40% | 929,577 | 43.74M |
| 36 | PTCT | PTC Therapeutics, Inc. | 6.10B | -0.30% | 884,933 | 1.78B |
| 37 | PCVX | Vaxcyte, Inc. | 6.04B | 1.61% | 919,176 | - |
| 38 | BLTE | Belite Bio, Inc | 6.00B | -0.53% | 60,947 | - |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.46B | 0.09% | 577,647 | 209.22M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.40B | -4.31% | 3,500,294 | - |
| 41 | IMVT | Immunovant, Inc. | 5.15B | 0.28% | 990,836 | - |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.09B | -0.37% | 478,957 | - |
| 43 | CRSP | CRISPR Therapeutics AG | 5.00B | -1.41% | 1,383,496 | 38.34M |
| 44 | GPCR | Structure Therapeutics Inc. | 4.81B | 2.61% | 1,015,243 | - |
| 45 | CELC | Celcuity Inc. | 4.62B | -0.18% | 493,444 | - |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 4.52B | 0.04% | 768,166 | 1.05B |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.49B | 0.99% | 642,358 | - |
| 48 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.42B | -1.77% | 601,729 | 1.54M |
| 49 | TERN | Terns Pharmaceuticals, Inc. | 4.39B | -0.47% | 1,532,222 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.39B | -0.07% | 6,695,856 | 598.70M |
| 51 | TGTX | TG Therapeutics, Inc. | 4.36B | 0.20% | 1,399,332 | 531.90M |
| 52 | ADMA | ADMA Biologics, Inc. | 4.34B | -0.65% | 1,936,643 | 488.56M |
| 53 | MIRM | Mirum Pharmaceuticals, Inc. | 4.06B | 0.18% | 454,767 | 471.79M |
| 54 | LEGN | Legend Biotech Corporation | 4.02B | 0.98% | 1,181,340 | 909.05M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 3.98B | 0.98% | 1,049,687 | 35.24M |
| 56 | VKTX | Viking Therapeutics, Inc. | 3.98B | -0.40% | 2,147,438 | - |
| 57 | ACLX | Arcellx, Inc. | 3.77B | 2.52% | 702,413 | 35.90M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.72B | -0.65% | 86,438 | 251.23M |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.66B | -50.43% | 20,305,349 | 741.17M |
| 60 | CNTA | Centessa Pharmaceuticals plc | 3.65B | 1.09% | 736,616 | 15.00M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.59B | -1.04% | 1,056,044 | - |
| 62 | ARQT | Arcutis Biotherapeutics, Inc. | 3.56B | 3.42% | 1,873,613 | 317.93M |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.48B | -0.55% | 654,409 | 366.10M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.46B | 1.59% | 1,095,105 | 7.50M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.42B | 1.41% | 936,588 | 435.83M |
| 66 | CGON | CG Oncology, Inc. | 3.35B | 3.36% | 722,152 | 2.17M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.22B | 1.87% | 1,433,841 | - |
| 68 | APLS | Apellis Pharmaceuticals, Inc. | 3.18B | -0.48% | 954,780 | 1.02B |
| 69 | WVE | Wave Life Sciences Ltd. | 3.11B | -0.87% | 1,689,108 | 109.23M |
| 70 | NUVB | Nuvation Bio Inc. | 3.07B | 0.22% | 3,762,300 | 26.75M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.03B | 0.17% | 610,534 | 214.83M |
| 72 | LQDA | Liquidia Corporation | 3.00B | 0.17% | 945,071 | 69.22M |
| 73 | IRON | Disc Medicine, Inc. | 3.00B | 3.28% | 394,309 | - |
| 74 | VRDN | Viridian Therapeutics, Inc. | 2.97B | 0.32% | 942,470 | 70.79M |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.95B | 2.58% | 1,715,198 | 240.00M |
| 76 | MLYS | Mineralys Therapeutics, Inc. | 2.87B | 2.23% | 1,019,056 | - |
| 77 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.87B | 0.21% | 829,485 | 578.20M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.74B | -0.36% | 869,140 | 55.70M |
| 79 | EWTX | Edgewise Therapeutics, Inc. | 2.63B | 1.12% | 1,087,903 | - |
| 80 | OCUL | Ocular Therapeutix, Inc. | 2.59B | -0.53% | 2,015,864 | 55.78M |
| 81 | DNLI | Denali Therapeutics Inc. | 2.58B | 0.61% | 1,159,499 | - |
| 82 | SYRE | Spyre Therapeutics, Inc. | 2.54B | 2.76% | 533,166 | - |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.53B | -3.35% | 300,548 | 664.23M |
| 84 | SLNO | Soleno Therapeutics, Inc. | 2.49B | 0.02% | 1,752,403 | 98.68M |
| 85 | ADPT | Adaptive Biotechnologies Corporation | 2.48B | -1.10% | 1,969,458 | 252.75M |
| 86 | AAPG | Ascentage Pharma Group International | 2.47B | 0.65% | 966 | 54.52M |
| 87 | MESO | Mesoblast Limited | 2.33B | -2.91% | 245,996 | 17.20M |
| 88 | SRPT | Sarepta Therapeutics, Inc. | 2.26B | 0.14% | 1,845,157 | 2.41B |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.22B | 0.97% | 3,675,794 | 630.60M |
| 90 | GLPG | Galapagos NV | 2.17B | 0.21% | 49,634 | 336.64M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.16B | -0.58% | 400,283 | 825.94M |
| 92 | RXRX | Recursion Pharmaceuticals, Inc. | 2.13B | -0.49% | 15,216,166 | 43.69M |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | 0.82% | 667,956 | 265.81M |
| 94 | MAZE | Maze Therapeutics, Inc. | 1.99B | 3.45% | 394,842 | 2.50M |
| 95 | ZYME | Zymeworks Inc. | 1.97B | -0.79% | 457,603 | 134.48M |
| 96 | IMNM | Immunome, Inc. | 1.97B | 1.42% | 1,344,726 | 9.68M |
| 97 | OLMA | Olema Pharmaceuticals, Inc. | 1.97B | -0.28% | 949,246 | - |
| 98 | ZLAB | Zai Lab Limited | 1.96B | 0.06% | 574,276 | 441.63M |
| 99 | IBRX | ImmunityBio, Inc. | 1.95B | - | 9,884,836 | 82.56M |
| 100 | ZBIO | Zenas BioPharma, Inc. | 1.95B | -0.74% | 381,112 | 15.00M |
| 101 | NRIX | Nurix Therapeutics, Inc. | 1.92B | -0.26% | 885,089 | 83.69M |
| 102 | SION | Sionna Therapeutics, Inc. | 1.84B | -0.60% | 328,791 | - |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | 1.30% | 861,844 | 111.30M |
| 104 | VCEL | Vericel Corporation | 1.82B | -1.96% | 360,197 | 258.72M |
| 105 | STOK | Stoke Therapeutics, Inc. | 1.81B | -0.25% | 422,865 | 205.63M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.80B | 2.76% | 722,719 | 2.60M |
| 107 | PHVS | Pharvaris N.V. | 1.80B | 5.71% | 423,492 | - |
| 108 | DNTH | Dianthus Therapeutics, Inc. | 1.77B | 0.61% | 444,415 | 3.08M |
| 109 | IMCR | Immunocore Holdings plc | 1.75B | 1.47% | 386,992 | 379.59M |
| 110 | MNKD | MannKind Corporation | 1.74B | 0.18% | 2,374,348 | 313.79M |
| 111 | TRVI | Trevi Therapeutics, Inc. | 1.61B | -0.32% | 972,849 | - |
| 112 | FTRE | Fortrea Holdings Inc. | 1.59B | -0.75% | 1,289,057 | 2.76B |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.59B | -0.40% | 838,807 | 44.79M |
| 114 | EYPT | EyePoint, Inc. | 1.51B | 2.12% | 630,021 | 42.34M |
| 115 | TSHA | Taysha Gene Therapies, Inc. | 1.51B | -2.83% | 2,685,105 | 6.31M |
| 116 | BHVN | Biohaven Ltd. | 1.50B | -3.01% | 2,293,277 | - |
| 117 | INVA | Innoviva, Inc. | 1.49B | 0.50% | 556,761 | 388.52M |
| 118 | CAPR | Capricor Therapeutics, Inc. | 1.49B | -0.35% | 1,384,740 | 11.13M |
| 119 | QURE | uniQure N.V. | 1.49B | 0.63% | 930,034 | 15.75M |
| 120 | ATAI | Atai Beckley N.V. | 1.49B | 2.76% | 3,944,965 | 3.02M |
| 121 | KOD | Kodiak Sciences Inc. | 1.48B | 0.04% | 1,580,673 | - |
| 122 | PGEN | Precigen, Inc. | 1.48B | -1.88% | 3,972,293 | 6.31M |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.47B | 4.09% | 560,314 | - |
| 124 | UPB | Upstream Bio, Inc. | 1.47B | -0.62% | 517,806 | 2.80M |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.47B | 1.32% | 2,029,570 | 8.36M |
| 126 | SVRA | Savara Inc. | 1.46B | -1.31% | 2,409,447 | - |
| 127 | RAPP | Rapport Therapeutics, Inc. | 1.45B | -0.98% | 435,442 | - |
| 128 | ARDX | Ardelyx, Inc. | 1.42B | 0.52% | 3,318,947 | 398.23M |
| 129 | MBX | MBX Biosciences, Inc. | 1.42B | 2.07% | 362,305 | - |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.40B | 3.34% | 585,225 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.34B | 0.52% | 367,138 | 169.47M |
| 132 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.33B | 0.67% | 1,964,056 | -665.00K |
| 133 | MNMD | Mind Medicine (MindMed) Inc. | 1.32B | 3.40% | 1,109,813 | - |
| 134 | XERS | Xeris Biopharma Holdings, Inc. | 1.30B | 7.39% | 5,331,431 | 266.14M |
| 135 | IMTX | Immatics N.V. | 1.28B | 4.27% | 501,636 | 99.45M |
| 136 | SEPN | Septerna, Inc. | 1.25B | 0.43% | 167,274 | 22.05M |
| 137 | PVLA | Palvella Therapeutics, Inc. | 1.24B | 4.80% | 389,393 | - |
| 138 | OMER | Omeros Corporation | 1.22B | 1.27% | 2,807,076 | - |
| 139 | TNGX | Tango Therapeutics, Inc. | 1.19B | 2.67% | 2,860,528 | 66.50M |
| 140 | PHAT | Phathom Pharmaceuticals, Inc. | 1.16B | -1.95% | 582,921 | 147.19M |
| 141 | OCS | Oculis Holding AG | 1.15B | 0.20% | 64,661 | 992.00K |
| 142 | SPRY | ARS Pharmaceuticals, Inc. | 1.15B | 0.09% | 1,026,019 | 142.77M |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.15B | 1.31% | 293,310 | 1.40M |
| 144 | PHAR | Pharming Group N.V. | 1.15B | 5.12% | 26,726 | 362.27M |
| 145 | NBTX | Nanobiotix S.A. | 1.10B | 6.69% | 15,914 | 11.93M |
| 146 | URGN | UroGen Pharma Ltd. | 1.10B | 1.04% | 654,517 | 96.52M |
| 147 | XNCR | Xencor, Inc. | 1.09B | 1.86% | 423,421 | 150.13M |
| 148 | NVAX | Novavax, Inc. | 1.09B | - | 2,757,036 | 1.06B |
| 149 | SANA | Sana Biotechnology, Inc. | 1.08B | -0.25% | 2,714,565 | - |
| 150 | IOVA | Iovance Biotherapeutics, Inc. | 1.08B | -1.44% | 11,174,730 | 250.43M |
| 151 | ERAS | Erasca, Inc. | 1.06B | 5.08% | 2,065,884 | - |
| 152 | NTLA | Intellia Therapeutics, Inc. | 1.04B | -0.77% | 3,020,988 | 57.53M |
| 153 | ABCL | AbCellera Biologics Inc. | 1.02B | -0.87% | 7,649,154 | 35.33M |
| 154 | GLUE | Monte Rosa Therapeutics, Inc. | 1.02B | -1.82% | 736,014 | 181.54M |
| 155 | ALMS | Alumis Inc. | 1.02B | -1.21% | 873,729 | 22.12M |
| 156 | CVAC | CureVac N.V. | 1.02B | 0.89% | 1,904,238 | 83.00M |
| 157 | MDXG | MiMedx Group, Inc. | 1.00B | -1.31% | 436,748 | 393.44M |
| 158 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.00B | 1.21% | 104,161 | - |
| 159 | DAWN | Day One Biopharmaceuticals, Inc. | 956.94M | 1.53% | 991,888 | 133.67M |
| 160 | CMPX | Compass Therapeutics, Inc. | 955.12M | -0.19% | 1,834,373 | 850.00K |
| 161 | TBPH | Theravance Biopharma, Inc. | 948.08M | -1.06% | 497,921 | 80.33M |
| 162 | MLTX | MoonLake Immunotherapeutics | 940.70M | -0.23% | 780,486 | - |
| 163 | RAPT | RAPT Therapeutics, Inc. | 938.57M | 1.47% | 228,349 | - |
| 164 | ABUS | Arbutus Biopharma Corporation | 925.08M | 4.11% | 3,069,622 | 14.61M |
| 165 | BCAX | Bicara Therapeutics Inc. | 921.98M | 4.40% | 352,985 | - |
| 166 | CRMD | CorMedix Inc. | 916.32M | -6.81% | 3,587,395 | 214.30M |
| 167 | ELVN | Enliven Therapeutics, Inc. | 913.95M | -0.96% | 536,166 | - |
| 168 | KURA | Kura Oncology, Inc. | 904.11M | 1.66% | 877,912 | 104.03M |
| 169 | IVA | Inventiva S.A. | 884.84M | 0.65% | 227,693 | 19.93M |
| 170 | NKTR | Nektar Therapeutics | 860.04M | 0.91% | 899,854 | 62.60M |
| 171 | YDES | YD Bio Limited | 857.20M | 2.09% | 15,931 | 510.36K |
| 172 | GERN | Geron Corporation | 842.63M | -1.49% | 5,341,793 | 183.40M |
| 173 | VIR | Vir Biotechnology, Inc. | 838.92M | 3.25% | 1,496,890 | 16.86M |
| 174 | MRVI | Maravai LifeSciences Holdings, Inc. | 831.05M | -0.61% | 1,371,323 | 192.44M |
| 175 | AVBP | ArriVent BioPharma, Inc. | 830.58M | -2.90% | 613,189 | - |
| 176 | JANX | Janux Therapeutics, Inc. | 830.04M | -0.22% | 1,486,643 | 10.00M |
| 177 | KALV | KalVista Pharmaceuticals, Inc. | 816.32M | 3.00% | 1,295,111 | 1.43M |
| 178 | ORIC | ORIC Pharmaceuticals, Inc. | 796.64M | 1.24% | 866,918 | - |
| 179 | GHRS | GH Research PLC | 787.77M | 1.60% | 87,476 | - |
| 180 | RIGL | Rigel Pharmaceuticals, Inc. | 777.42M | - | 900,920 | 282.08M |
| 181 | MPLT | MapLight Therapeutics, Inc. | 766.56M | -2.06% | 245,017 | - |
| 182 | REPL | Replimune Group, Inc. | 762.47M | -1.02% | 1,512,443 | - |
| 183 | ARVN | Arvinas, Inc. | 761.70M | 1.11% | 512,485 | 312.30M |
| 184 | VALN | Valneva SE | 754.16M | 6.11% | 50,472 | 211.09M |
| 185 | ANNX | Annexon, Inc. | 748.26M | -0.40% | 2,097,708 | - |
| 186 | ATXS | Astria Therapeutics, Inc. | 747.24M | 0.77% | 298,911 | 706.00K |
| 187 | FULC | Fulcrum Therapeutics, Inc. | 746.12M | -0.26% | 931,915 | 80.00M |
| 188 | RGNX | REGENXBIO Inc. | 728.97M | 2.27% | 656,697 | 161.32M |
| 189 | LXEO | Lexeo Therapeutics, Inc. | 724.76M | 1.95% | 1,075,750 | - |
| 190 | CTMX | CytomX Therapeutics, Inc. | 721.79M | 2.40% | 1,155,738 | 113.63M |
| 191 | GOSS | Gossamer Bio, Inc. | 717.51M | -0.64% | 3,443,557 | 44.05M |
| 192 | DBVT | DBV Technologies S.A. | 713.02M | -0.21% | 387,263 | 5.50M |
| 193 | NBY | NovaBay Pharmaceuticals, Inc. | 710.70M | -9.03% | 785,053 | 10.30M |
| 194 | JBIO | Jade Biosciences, Inc. | 709.84M | -0.84% | 433,130 | - |
| 195 | PROK | ProKidney Corp. | 673.87M | 1.82% | 1,133,824 | 744.00K |
| 196 | LYEL | Lyell Immunopharma, Inc. | 653.10M | -2.56% | 193,485 | 41.00K |
| 197 | VTYX | Ventyx Biosciences, Inc. | 644.37M | 3.20% | 590,811 | - |
| 198 | GYRE | Gyre Therapeutics, Inc. | 641.69M | 0.57% | 61,865 | 107.27M |
| 199 | MGTX | MeiraGTx Holdings plc | 639.90M | 1.02% | 302,834 | 27.42M |
| 200 | DRUG | Bright Minds Biosciences Inc. | 627.18M | 3.37% | 297,386 | - |
| 201 | KROS | Keros Therapeutics, Inc. | 620.29M | 0.44% | 230,141 | 246.72M |
| 202 | PRME | Prime Medicine, Inc. | 614.32M | 0.87% | 3,971,560 | 5.98M |
| 203 | CGEM | Cullinan Therapeutics, Inc. | 611.44M | 4.33% | 664,914 | - |
| 204 | ENGN | enGene Holdings Inc. | 604.87M | 0.89% | 103,186 | - |
| 205 | VSTM | Verastem, Inc. | 595.84M | 2.39% | 990,085 | 13.38M |
| 206 | IVVD | Invivyd, Inc. | 575.81M | 1.65% | 1,952,883 | 50.04M |
| 207 | CRVS | Corvus Pharmaceuticals, Inc. | 575.05M | 2.80% | 1,137,330 | - |
| 208 | LBRX | LB Pharmaceuticals Inc | 563.16M | 3.53% | 262,668 | - |
| 209 | ANRO | Alto Neuroscience, Inc. | 552.98M | -0.78% | 200,556 | - |
| 210 | EVMN | Evommune, Inc. | 539.69M | -2.28% | 149,807 | 13.00M |
| 211 | ASMB | Assembly Biosciences, Inc. | 537.94M | 5.85% | 91,389 | 37.19M |
| 212 | KYTX | Kyverna Therapeutics, Inc. | 537.02M | 0.53% | 770,917 | - |
| 213 | SLS | SELLAS Life Sciences Group, Inc. | 537.01M | 13.90% | 23,221,254 | - |
| 214 | DSGN | Design Therapeutics, Inc. | 534.32M | -4.39% | 809,724 | - |
| 215 | AUTL | Autolus Therapeutics plc | 529.63M | 1.02% | 3,200,808 | 51.13M |
| 216 | ABSI | Absci Corporation | 524.80M | - | 1,983,819 | 2.82M |
| 217 | VNDA | Vanda Pharmaceuticals Inc. | 521.23M | 25.46% | 23,812,044 | 212.07M |
| 218 | PRTA | Prothena Corporation plc | 514.08M | 2.58% | 466,240 | 11.79M |
| 219 | NAGE | Niagen Bioscience, Inc. | 509.37M | -1.85% | 860,364 | 124.71M |
| 220 | VOR | Vor Biopharma Inc. | 506.46M | 4.39% | 564,738 | - |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 504.43M | 1.70% | 1,344,014 | 84.39M |
| 222 | LENZ | LENZ Therapeutics, Inc. | 500.64M | -0.74% | 885,158 | 17.50M |
| 223 | VTVT | vTv Therapeutics Inc. | 496.23M | 2.59% | 17,445 | 17.00K |
| 224 | TENX | Tenax Therapeutics, Inc. | 494.55M | 1.63% | 67,178 | - |
| 225 | BCYC | Bicycle Therapeutics plc | 491.12M | 3.68% | 231,575 | 28.34M |
| 226 | FBRX | Forte Biosciences, Inc. | 486.26M | 3.81% | 125,497 | - |
| 227 | DNA | Ginkgo Bioworks Holdings, Inc. | 472.31M | 1.96% | 1,062,329 | 180.61M |
| 228 | NBP | NovaBridge Biosciences | 458.86M | 0.51% | 433,944 | - |
| 229 | BNTC | Benitec Biopharma Inc. | 456.12M | -3.30% | 417,519 | - |
| 230 | ENTA | Enanta Pharmaceuticals, Inc. | 455.16M | -0.82% | 478,782 | 65.32M |
| 231 | PEPG | PepGen Inc. | 447.55M | 1.40% | 457,545 | - |
| 232 | SLDB | Solid Biosciences Inc. | 439.41M | -1.05% | 1,044,904 | - |
| 233 | ADCT | ADC Therapeutics SA | 437.29M | 0.86% | 555,938 | 75.21M |
| 234 | MNPR | Monopar Therapeutics Inc. | 436.37M | 0.35% | 285,412 | - |
| 235 | FDMT | 4D Molecular Therapeutics, Inc. | 428.51M | -1.06% | 786,708 | 120.00K |
| 236 | IMRX | Immuneering Corporation | 424.87M | -2.23% | 1,168,370 | - |
| 237 | DRTS | Alpha Tau Medical Ltd. | 422.06M | -1.59% | 142,705 | - |
| 238 | OCGN | Ocugen, Inc. | 421.63M | -1.46% | 2,577,462 | 5.37M |
| 239 | LXRX | Lexicon Pharmaceuticals, Inc. | 417.91M | - | 1,790,375 | 70.86M |
| 240 | DMAC | DiaMedica Therapeutics Inc. | 414.54M | -1.12% | 167,410 | - |
| 241 | CYBN | Cybin Inc. | 408.21M | -4.55% | 1,192,659 | - |
| 242 | IMMP | Immutep Limited | 407.95M | -2.39% | 158,375 | 3.31M |
| 243 | PRTC | PureTech Health plc | 406.60M | 2.76% | 189 | 6.39M |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 404.69M | 4.37% | 1,111,067 | 10.82M |
| 245 | TECX | Tectonic Therapeutic, Inc. | 390.42M | -0.62% | 206,964 | - |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 381.21M | -0.53% | 63,479 | - |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | 379.86M | 2.63% | 2,166,419 | - |
| 248 | ALT | Altimmune, Inc. | 376.68M | - | 4,290,103 | 20.00K |
| 249 | TRDA | Entrada Therapeutics, Inc. | 368.66M | 1.88% | 137,932 | 61.52M |
| 250 | CLLS | Cellectis S.A. | 356.23M | 0.84% | 73,572 | 82.55M |
| 251 | RLMD | Relmada Therapeutics, Inc. | 354.20M | 6.62% | 806,973 | - |
| 252 | PALI | Palisade Bio, Inc. | 350.16M | -0.42% | 4,287,207 | - |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 349.75M | -3.85% | 340,105 | 33.98M |
| 254 | AURA | Aura Biosciences, Inc. | 346.09M | -0.73% | 126,813 | - |
| 255 | ZURA | Zura Bio Limited | 340.72M | -1.50% | 526,457 | - |
| 256 | CTNM | Contineum Therapeutics, Inc. | 333.56M | 0.26% | 186,906 | - |
| 257 | AVTX | Avalo Therapeutics, Inc. | 329.31M | 1.97% | 128,724 | 192.00K |
| 258 | XOMA | XOMA Royalty Corporation | 329.27M | 1.57% | 834,273 | 47.11M |
| 259 | ACRS | Aclaris Therapeutics, Inc. | 326.12M | 3.79% | 462,486 | 15.74M |
| 260 | LRMR | Larimar Therapeutics, Inc. | 326.10M | -2.56% | 907,856 | - |
| 261 | NGNE | Neurogene Inc. | 319.09M | -7.15% | 157,618 | 925.00K |
| 262 | AVXL | Anavex Life Sciences Corp. | 318.08M | -6.32% | 1,513,295 | - |
| 263 | ALDX | Aldeyra Therapeutics, Inc. | 311.64M | 0.58% | 554,125 | - |
| 264 | ACIU | AC Immune SA | 310.68M | -0.32% | 258,725 | 5.48M |
| 265 | CADL | Candel Therapeutics, Inc. | 310.18M | -1.05% | 688,993 | - |
| 266 | ALLO | Allogene Therapeutics, Inc. | 307.88M | 4.58% | 3,053,512 | 22.00K |
| 267 | FHTX | Foghorn Therapeutics Inc. | 305.38M | 4.85% | 146,765 | 24.52M |
| 268 | NMRA | Neumora Therapeutics, Inc. | 304.19M | 1.13% | 754,132 | - |
| 269 | MENS | Jyong Biotech Ltd. | 303.76M | -6.40% | 1,874,521 | - |
| 270 | GUTS | Fractyl Health, Inc. | 301.50M | -1.79% | 1,507,244 | 3.00K |
| 271 | PBYI | Puma Biotechnology, Inc. | 299.83M | -1.00% | 227,582 | 212.00M |
| 272 | GLSI | Greenwich LifeSciences, Inc. | 291.08M | -4.15% | 662,129 | - |
| 273 | CAMP | Camp4 Therapeutics Corporation | 287.38M | 4.07% | 150,771 | 3.80M |
| 274 | SLN | Silence Therapeutics plc | 287.18M | -1.14% | 581,604 | 25.83M |
| 275 | AARD | Aardvark Therapeutics, Inc. | 285.77M | -0.79% | 87,278 | - |
| 276 | TARA | Protara Therapeutics, Inc. | 285.62M | 1.52% | 586,137 | - |
| 277 | ABEO | Abeona Therapeutics Inc. | 285.59M | 1.74% | 920,038 | 400.00K |
| 278 | IKT | Inhibikase Therapeutics, Inc. | 280.40M | 4.06% | 506,198 | 1.00 |
| 279 | AVIR | Atea Pharmaceuticals, Inc. | 278.91M | 0.56% | 385,963 | - |
| 280 | IMMX | Immix Biopharma, Inc. | 275.60M | -1.33% | 746,279 | - |
| 281 | GALT | Galectin Therapeutics Inc. | 268.21M | 1.96% | 325,555 | - |
| 282 | OABI | OmniAb, Inc. | 266.32M | -0.54% | 438,623 | 21.09M |
| 283 | ACHV | Achieve Life Sciences, Inc. | 264.57M | 5.74% | 823,322 | - |
| 284 | FENC | Fennec Pharmaceuticals Inc. | 262.98M | -0.77% | 106,077 | 38.79M |
| 285 | NAUT | Nautilus Biotechnology, Inc. | 246.29M | 2.09% | 136,656 | - |
| 286 | PRLD | Prelude Therapeutics Incorporated | 238.95M | 2.11% | 218,422 | 10.50M |
| 287 | HRTX | Heron Therapeutics, Inc. | 238.37M | -3.70% | 1,173,087 | 155.10M |
| 288 | MDWD | MediWound Ltd. | 236.68M | 1.10% | 71,509 | 20.93M |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 234.33M | 0.24% | 94,240 | 2.82M |
| 290 | CBIO | Crescent Biopharma, Inc. | 231.86M | 2.24% | 51,060 | - |
| 291 | STTK | Shattuck Labs, Inc. | 230.97M | 1.39% | 783,706 | 1.00M |
| 292 | ARMP | Armata Pharmaceuticals, Inc. | 228.64M | 0.64% | 7,525 | 5.05M |
| 293 | RZLT | Rezolute, Inc. | 218.84M | 7.76% | 4,313,415 | - |
| 294 | VYGR | Voyager Therapeutics, Inc. | 218.51M | -0.25% | 452,950 | 31.32M |
| 295 | PRQR | ProQR Therapeutics N.V. | 212.80M | 1.00% | 319,924 | 18.86M |
| 296 | OVID | Ovid Therapeutics Inc. | 212.20M | - | 906,139 | 6.61M |
| 297 | CABA | Cabaletta Bio, Inc. | 210.82M | 1.86% | 1,156,958 | - |
| 298 | MIST | Milestone Pharmaceuticals Inc. | 205.20M | 3.06% | 2,369,845 | - |
| 299 | EDIT | Editas Medicine, Inc. | 200.12M | 0.49% | 1,708,999 | 46.38M |
| 300 | SRZN | Surrozen, Inc. | 193.71M | 4.97% | 75,273 | 3.60M |
| 301 | NVCT | Nuvectis Pharma, Inc. | 193.39M | 2.30% | 117,814 | - |
| 302 | SGMT | Sagimet Biosciences Inc. | 192.53M | 1.20% | 265,816 | - |
| 303 | CLYM | Climb Bio, Inc. | 190.98M | -0.74% | 635,950 | - |
| 304 | CRDF | Cardiff Oncology, Inc. | 189.28M | -2.09% | 690,617 | 501.00K |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 187.49M | 3.89% | 368,372 | 1.09M |
| 306 | QNCX | Quince Therapeutics, Inc. | 186.53M | 2.76% | 467,936 | - |
| 307 | HUMA | Humacyte, Inc. | 185.37M | -4.90% | 10,290,697 | 1.57M |
| 308 | CCCC | C4 Therapeutics, Inc. | 185.11M | -2.55% | 917,944 | 30.11M |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 183.95M | -1.26% | 604,567 | 10.30M |
| 310 | SABS | SAB Biotherapeutics, Inc. | 178.05M | -0.80% | 69,691 | 114.70K |
| 311 | TLSA | Tiziana Life Sciences Ltd | 177.05M | -3.25% | 231,156 | - |
| 312 | ARCT | Arcturus Therapeutics Holdings Inc. | 174.17M | -0.97% | 635,056 | 97.60M |
| 313 | IPHA | Innate Pharma S.A. | 173.38M | 2.30% | 15,348 | 14.84M |
| 314 | CHRS | Coherus Oncology, Inc. | 171.64M | 1.21% | 1,165,380 | 277.73M |
| 315 | ALEC | Alector, Inc. | 170.28M | 2.63% | 768,251 | 69.05M |
| 316 | RANI | Rani Therapeutics Holdings, Inc. | 164.05M | - | 1,314,497 | 1.20M |
| 317 | GNLX | Genelux Corporation | 164.02M | 0.46% | 83,283 | 8.00K |
| 318 | NTHI | NeOnc Technologies Holdings, Inc. | 161.05M | 0.79% | 32,645 | 59.99K |
| 319 | MOLN | Molecular Partners AG | 160.13M | 1.36% | 1,260 | 856.30K |
| 320 | KLRS | Kalaris Therapeutics, Inc. | 157.85M | 0.72% | 119,375 | - |
| 321 | CNTB | Connect Biopharma Holdings Limited | 157.65M | 4.44% | 133,965 | 762.00K |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 150.82M | 1.62% | 184,445 | - |
| 323 | CRBU | Caribou Biosciences, Inc. | 148.61M | - | 1,248,665 | 9.30M |
| 324 | CDXS | Codexis, Inc. | 147.23M | 1.87% | 914,137 | 52.93M |
| 325 | PLX | Protalix BioTherapeutics, Inc. | 144.76M | 3.45% | 624,124 | 61.84M |
| 326 | MRSN | Mersana Therapeutics, Inc. | 144.61M | 0.98% | 174,628 | 33.18M |
| 327 | CGEN | Compugen Ltd. | 143.11M | 3.38% | 313,427 | 6.90M |
| 328 | ACTU | Actuate Therapeutics, Inc. | 142.25M | 1.66% | 56,319 | - |
| 329 | SGMO | Sangamo Therapeutics, Inc. | 141.33M | -1.71% | 4,940,298 | 32.88M |
| 330 | ACOG | Alpha Cognition Inc. | 141.32M | -1.52% | 49,164 | 7.43M |
| 331 | ELTX | Elicio Therapeutics, Inc. | 139.10M | 0.63% | 75,986 | - |
| 332 | IRD | Opus Genetics, Inc. | 138.62M | 3.08% | 221,614 | 14.63M |
| 333 | BDTX | Black Diamond Therapeutics, Inc. | 138.45M | -2.41% | 1,423,367 | 70.00M |
| 334 | CNTX | Context Therapeutics Inc. | 135.06M | 13.08% | 845,419 | - |
| 335 | MCRB | Seres Therapeutics, Inc. | 134.61M | 2.84% | 54,222 | 351.00K |
| 336 | VRCA | Verrica Pharmaceuticals Inc. | 132.88M | 0.12% | 154,157 | 30.83M |
| 337 | NKTX | Nkarta, Inc. | 131.40M | 1.09% | 678,973 | - |
| 338 | SPRO | Spero Therapeutics, Inc. | 131.27M | 2.64% | 216,812 | 40.55M |
| 339 | ATRA | Atara Biotherapeutics, Inc. | 130.43M | 1.17% | 66,485 | 151.93M |
| 340 | ABOS | Acumen Pharmaceuticals, Inc. | 127.81M | 5.76% | 184,160 | - |
| 341 | KPTI | Karyopharm Therapeutics Inc. | 125.49M | 0.68% | 141,557 | 142.53M |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 124.01M | 3.22% | 283,671 | - |
| 343 | GANX | Gain Therapeutics, Inc. | 123.85M | 5.57% | 688,310 | - |
| 344 | DWTX | Dogwood Therapeutics, Inc. | 123.67M | 0.48% | 11,353 | - |
| 345 | COYA | Coya Therapeutics, Inc. | 121.36M | 4.69% | 161,091 | 3.99M |
| 346 | INO | Inovio Pharmaceuticals, Inc. | 119.54M | -1.14% | 1,353,348 | 182.34K |
| 347 | CGTX | Cognition Therapeutics, Inc. | 119.17M | -1.46% | 1,060,663 | - |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 118.47M | 1.64% | 2,970,927 | - |
| 349 | SLGL | Sol-Gel Technologies Ltd. | 117.39M | -0.75% | 37,853 | 18.97M |
| 350 | TTRX | Turn Therapeutics Inc. | 116.01M | 6.20% | 148,058 | - |
| 351 | WHWK | Whitehawk Therapeutics, Inc. | 114.05M | -2.02% | 164,277 | 14.38M |
| 352 | FBIO | Fortress Biotech, Inc. | 113.60M | 2.23% | 453,718 | 62.30M |
| 353 | ELDN | Eledon Pharmaceuticals, Inc. | 113.47M | - | 1,275,393 | - |
| 354 | ORMP | Oramed Pharmaceuticals Inc. | 113.44M | 1.42% | 108,878 | 2.00M |
| 355 | FATE | Fate Therapeutics, Inc. | 113.35M | -0.06% | 810,720 | 7.14M |
| 356 | RPTX | Repare Therapeutics Inc. | 112.08M | 0.78% | 474,098 | 11.87M |
| 357 | AGEN | Agenus Inc. | 106.79M | 0.64% | 402,628 | 106.83M |
| 358 | THAR | Tharimmune, Inc. | 106.19M | 1.34% | 453,406 | - |
| 359 | ARTV | Artiva Biotherapeutics, Inc. | 105.30M | 2.63% | 118,709 | 251.00K |
| 360 | SEER | Seer, Inc. | 102.94M | 0.55% | 157,263 | 16.38M |
| 361 | ANIX | Anixa Biosciences, Inc. | 102.70M | - | 184,826 | - |
| 362 | MGNX | MacroGenics, Inc. | 101.85M | 3.21% | 910,258 | 127.63M |
| 363 | OTLK | Outlook Therapeutics, Inc. | 101.30M | -15.28% | 34,077,365 | 1.41M |
| 364 | DTIL | Precision BioSciences, Inc. | 100.14M | -5.88% | 386,992 | 698.00K |
| 365 | STRO | Sutro Biopharma, Inc. | 98.57M | -0.86% | 113,374 | 105.65M |
| 366 | CSBR | Champions Oncology, Inc. | 95.95M | 5.50% | 5,647 | 58.42M |
| 367 | PTHS | Pelthos Therapeutics Inc. | 95.69M | 12.77% | 124,001 | 7.41M |
| 368 | SAVA | Cassava Sciences, Inc. | 95.65M | -2.46% | 994,644 | - |
| 369 | CALC | CalciMedica, Inc. | 94.96M | 15.01% | 118,115 | - |
| 370 | CBUS | Cibus, Inc. | 94.45M | 2.96% | 280,353 | 3.79M |
| 371 | EQ | Equillium, Inc. | 94.38M | - | 535,943 | 4.39M |
| 372 | ONCY | Oncolytics Biotech Inc. | 94.05M | -1.48% | 676,513 | - |
| 373 | SPRB | Spruce Biosciences, Inc. | 93.24M | 5.37% | 29,332 | 697.00K |
| 374 | ETHZ | ETHZilla Corporation | 92.79M | -1.80% | 1,068,804 | 4.11M |
| 375 | ANVS | Annovis Bio, Inc. | 91.70M | - | 354,824 | - |
| 376 | EXOZ | eXoZymes, Inc. | 91.42M | -1.98% | 9,311 | -700.00 |
| 377 | VANI | Vivani Medical, Inc. | 89.73M | - | 337,928 | - |
| 378 | ADAG | Adagene Inc. | 89.08M | 4.07% | 51,187 | 103.20K |
| 379 | ENTX | Entera Bio Ltd. | 88.96M | -3.00% | 117,605 | 124.00K |
| 380 | BMEA | Biomea Fusion, Inc. | 87.67M | 1.64% | 868,550 | - |
| 381 | ZNTL | Zentalis Pharmaceuticals, Inc. | 87.41M | 1.13% | 604,742 | 26.87M |
| 382 | IPSC | Century Therapeutics, Inc. | 86.86M | -0.42% | 471,584 | 113.34M |
| 383 | ACET | Adicet Bio, Inc. | 85.10M | 6.18% | 261,754 | - |
| 384 | HYFT | MindWalk Holdings Corp. | 84.98M | 5.51% | 365,081 | 19.02M |
| 385 | VXRT | Vaxart, Inc. | 83.13M | -1.68% | - | 148.20M |
| 386 | NRXP | NRx Pharmaceuticals, Inc. | 80.23M | 3.04% | 620,059 | 242.00K |
| 387 | OKYO | OKYO Pharma Limited | 77.85M | 6.70% | 37,156 | - |
| 388 | ATYR | aTyr Pharma, Inc. | 76.73M | 5.11% | 3,675,201 | 190.00K |
| 389 | ATOS | Atossa Therapeutics, Inc. | 76.21M | -5.07% | 3,717,949 | - |
| 390 | COEP | Coeptis Therapeutics Holdings, Inc. | 76.10M | -3.06% | 54,946 | 501.00K |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 76.05M | -1.23% | 222,966 | - |
| 392 | KRRO | Korro Bio, Inc. | 75.43M | 1.39% | 122,760 | 7.37M |
| 393 | KZIA | Kazia Therapeutics Limited | 75.08M | 6.66% | 144,760 | 1.20M |
| 394 | PLRX | Pliant Therapeutics, Inc. | 74.97M | 0.83% | 1,047,904 | - |
| 395 | TIL | Instil Bio, Inc. | 74.60M | 5.97% | 95,593 | - |
| 396 | IMA | ImageneBio, Inc. | 73.49M | -2.95% | 48,972 | 800.00K |
| 397 | CRVO | CervoMed Inc. | 73.10M | -1.25% | 68,091 | 6.16M |
| 398 | XBIT | XBiotech Inc. | 72.87M | 2.14% | 50,191 | - |
| 399 | PYPD | PolyPid Ltd. | 72.19M | -0.91% | 85,489 | - |
| 400 | PYXS | Pyxis Oncology, Inc. | 71.60M | 5.50% | 1,578,461 | 2.82M |
| 401 | PSTV | Plus Therapeutics, Inc. | 70.40M | -5.78% | 5,262,961 | 5.26M |
| 402 | IFRX | InflaRx N.V. | 68.42M | -0.98% | 595,574 | 73.73K |
| 403 | BYSI | BeyondSpring Inc. | 67.03M | -4.68% | 165,581 | 1.88M |
| 404 | PMVP | PMV Pharmaceuticals, Inc. | 66.51M | 2.46% | 326,281 | - |
| 405 | MREO | Mereo BioPharma Group plc | 66.31M | 12.47% | 46,210,638 | 500.00K |
| 406 | TVGN | Tevogen Bio Holdings Inc. | 65.79M | -2.27% | 716,583 | - |
| 407 | MNOV | MediciNova, Inc. | 64.38M | 1.55% | 66,017 | 257.92K |
| 408 | IMUX | Immunic, Inc. | 64.20M | 4.61% | 989,210 | - |
| 409 | ALXO | ALX Oncology Holdings Inc. | 61.27M | -5.04% | 281,479 | - |
| 410 | MGX | Metagenomi, Inc. | 60.83M | 1.25% | 503,543 | 30.91M |
| 411 | RADX | Radiopharm Theranostics Limited | 59.10M | 1.16% | 45,943 | 8.20M |
| 412 | ESLA | Estrella Immunopharma, Inc. | 58.91M | 1.96% | 58,250 | - |
| 413 | ATHE | Alterity Therapeutics Limited | 58.03M | 0.65% | 27,529 | 3.57M |
| 414 | ALGS | Aligos Therapeutics, Inc. | 57.35M | 2.19% | 54,171 | 2.65M |
| 415 | TCRX | TScan Therapeutics, Inc. | 56.75M | -2.91% | 310,130 | 8.42M |
| 416 | MAIA | MAIA Biotechnology, Inc. | 56.66M | 15.04% | 1,495,296 | - |
| 417 | ICCC | ImmuCell Corporation | 55.63M | 0.08% | 9,672 | 27.77M |
| 418 | NTRB | Nutriband Inc. | 55.19M | -2.78% | 27,314 | 2.28M |
| 419 | GRCE | Grace Therapeutics, Inc. | 53.54M | 2.67% | 190,729 | - |
| 420 | IBO | Impact BioMedical Inc. | 52.83M | 3.19% | 99,306 | 25.00K |
| 421 | ANL | Adlai Nortye Ltd. | 52.40M | -4.70% | 183,689 | -1.35M |
| 422 | INKT | MiNK Therapeutics, Inc. | 52.34M | -1.50% | 8,602 | - |
| 423 | JSPR | Jasper Therapeutics, Inc. | 51.21M | 2.23% | 451,792 | - |
| 424 | ABVC | ABVC BioPharma, Inc. | 50.21M | -0.93% | 91,786 | 797.92K |
| 425 | NXTC | NextCure, Inc. | 49.74M | 1.50% | 77,966 | - |
| 426 | OSTX | OS Therapies Incorporated | 49.30M | -5.41% | 556,177 | - |
| 427 | LITS | Lite Strategy, Inc. | 48.56M | -4.35% | 1,681,327 | - |
| 428 | NRXS | NeurAxis, Inc. | 48.36M | 0.67% | 174,365 | 3.36M |
| 429 | PTN | Palatin Technologies, Inc. | 47.18M | 6.14% | 144,459 | 8.85M |
| 430 | KZR | Kezar Life Sciences, Inc. | 46.06M | 0.64% | 7,362 | - |
| 431 | HURA | TuHURA Biosciences, Inc. | 45.95M | -0.25% | 430,083 | - |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | -0.75% | 217,832 | - |
| 433 | LPCN | Lipocine Inc. | 44.58M | 22.22% | 421,611 | 4.32M |
| 434 | IOBT | IO Biotech, Inc. | 43.81M | 4.78% | 990,713 | - |
| 435 | IBIO | iBio, Inc. | 43.40M | 12.87% | 1,010,014 | 500.00K |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 42.43M | -3.55% | 244,656 | 90.00K |
| 437 | CVM | CEL-SCI Corporation | 42.16M | 0.57% | 37,405 | - |
| 438 | PDSB | PDS Biotechnology Corporation | 42.12M | -4.15% | 669,525 | - |
| 439 | ANEB | Anebulo Pharmaceuticals, Inc. | 41.50M | 2.86% | 139,083 | - |
| 440 | INMB | INmune Bio, Inc. | 41.47M | -2.50% | 491,463 | 50.00K |
| 441 | QTTB | Q32 Bio Inc. | 40.85M | 3.75% | 135,861 | - |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 40.34M | 1.65% | 230,151 | - |
| 443 | APLM | Apollomics, Inc. | 40.12M | -9.60% | 41,765 | 6.93M |
| 444 | EVAX | Evaxion A/S | 39.78M | -0.21% | 84,748 | 7.65M |
| 445 | OKUR | OnKure Therapeutics, Inc. | 39.29M | 0.70% | 59,890 | - |
| 446 | GBIO | Generation Bio Co. | 38.27M | 1.61% | 46,790 | 15.27M |
| 447 | PASG | Passage Bio, Inc. | 37.51M | 9.81% | 43,216 | - |
| 448 | GLTO | Galecto, Inc. | 36.70M | 3.14% | 33,461 | - |
| 449 | FGEN | FibroGen, Inc. | 35.52M | 0.92% | 33,170 | 8.30M |
| 450 | JUNS | Jupiter Neurosciences, Inc. | 35.11M | -10.10% | 283,089 | - |
| 451 | BTAI | BioXcel Therapeutics, Inc. | 34.99M | 4.58% | 539,489 | 752.00K |
| 452 | GNTA | Genenta Science S.p.A. | 34.91M | 6.34% | 63,258 | - |
| 453 | XCUR | Exicure, Inc. | 34.55M | -1.45% | 42,126 | 500.00K |
| 454 | VERU | Veru Inc. | 34.35M | -1.38% | 237,071 | 16.89M |
| 455 | DYAI | Dyadic International, Inc. | 34.02M | 7.21% | 183,972 | 3.34M |
| 456 | LTRN | Lantern Pharma Inc. | 33.89M | -0.98% | 84,865 | - |
| 457 | XLO | Xilio Therapeutics, Inc. | 33.61M | -1.55% | 272,850 | 31.80M |
| 458 | BCAB | BioAtla, Inc. | 33.51M | -20.82% | 8,037,071 | 11.00M |
| 459 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 32.10M | 0.36% | 4,650,368 | - |
| 460 | CELU | Celularity Inc. | 31.45M | -1.33% | 199,739 | 40.58M |
| 461 | ANTX | AN2 Therapeutics, Inc. | 31.24M | 5.56% | 65,951 | - |
| 462 | RNXT | RenovoRx, Inc. | 30.79M | -3.94% | 122,576 | 928.00K |
| 463 | HOWL | Werewolf Therapeutics, Inc. | 30.75M | 3.63% | 404,326 | 1.14M |
| 464 | RNTX | Rein Therapeutics Inc. | 30.49M | 8.41% | 461,289 | - |
| 465 | ATHA | Athira Pharma, Inc. | 29.86M | 7.83% | 132,230 | - |
| 466 | CING | Cingulate Inc. | 29.33M | 3.33% | 115,792 | - |
| 467 | QNTM | Quantum BioPharma Ltd. | 29.23M | -0.41% | 117,322 | - |
| 468 | HYPD | Hyperion DeFi, Inc. | 29.09M | 5.64% | 327,545 | 345.32K |
| 469 | RLYB | Rallybio Corporation | 28.98M | 1.19% | 177,606 | 674.00K |
| 470 | KTTA | Pasithea Therapeutics Corp. | 28.89M | 12.17% | 836,424 | - |
| 471 | BRNS | Barinthus Biotherapeutics plc | 28.59M | 2.79% | 113,606 | 14.97M |
| 472 | NERV | Minerva Neurosciences, Inc. | 28.11M | -0.99% | 69,150 | - |
| 473 | PLUR | Pluri Inc. | 27.67M | 1.70% | 8,427 | 1.33M |
| 474 | DARE | Daré Bioscience, Inc. | 27.58M | -1.53% | 156,815 | -57.13K |
| 475 | SNTI | Senti Biosciences, Inc. | 27.34M | -0.95% | 437,968 | - |
| 476 | BOLD | Boundless Bio, Inc. | 26.86M | - | 101,222 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 26.14M | -2.39% | 2,765,148 | 721.00K |
| 478 | IGC | IGC Pharma, Inc. | 26.13M | -0.39% | 569,048 | 1.11M |
| 479 | MRKR | Marker Therapeutics, Inc. | 24.84M | 1.36% | 174,224 | 4.69M |
| 480 | INTS | Intensity Therapeutics, Inc. | 24.64M | 9.21% | 1,562,953 | - |
| 481 | CUE | Cue Biopharma, Inc. | 24.05M | 0.99% | 776,601 | 7.10M |
| 482 | SKYE | Skye Bioscience, Inc. | 24.03M | 3.12% | 811,148 | - |
| 483 | LIXT | Lixte Biotechnology Holdings, Inc. | 22.42M | 0.77% | 47,013 | - |
| 484 | NNVC | NanoViricides, Inc. | 22.06M | 2.73% | 264,335 | - |
| 485 | KLTO | Klotho Neurosciences, Inc. | 20.96M | -4.34% | 1,300,390 | - |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 20.86M | 4.02% | 50,828 | 15.65M |
| 487 | LNAI | Lunai Bioworks Inc. | 20.66M | -0.42% | 156,404 | - |
| 488 | SER | Serina Therapeutics, Inc. | 20.40M | -4.87% | 46,512 | 116.00K |
| 489 | VYNE | VYNE Therapeutics Inc. | 19.31M | 3.04% | 1,397,839 | 524.00K |
| 490 | NRSN | NeuroSense Therapeutics Ltd. | 19.26M | 8.34% | 284,841 | - |
| 491 | MTVA | MetaVia Inc. | 18.54M | -2.43% | 40,545 | - |
| 492 | CLGN | CollPlant Biotechnologies Ltd. | 17.89M | - | 43,690 | 2.48M |
| 493 | ITRM | Iterum Therapeutics plc | 17.68M | 16.28% | 7,204,298 | 390.00K |
| 494 | CASI | CASI Pharmaceuticals, Inc. | 17.47M | 11.84% | 31,157 | 26.85M |
| 495 | ENLV | Enlivex Therapeutics Ltd. | 17.08M | 4.64% | 363,117 | - |
| 496 | ALLR | Allarity Therapeutics, Inc. | 17.07M | 6.93% | 165,072 | - |
| 497 | PLRZ | Polyrizon Ltd. | 16.76M | 3.28% | 45,257 | - |
| 498 | LIMN | Liminatus Pharma, Inc. | 16.51M | -5.28% | 83,895 | - |
| 499 | LSTA | Lisata Therapeutics, Inc. | 16.41M | -4.43% | 50,297 | 1.07M |
| 500 | CTXR | Citius Pharmaceuticals, Inc. | 16.13M | -0.77% | 396,677 | - |
| 501 | CANF | Can-Fite BioPharma Ltd. | 16.08M | 8.99% | 3,845,959 | 560.00K |
| 502 | CVKD | Cadrenal Therapeutics, Inc. | 15.85M | 2.42% | 19,581 | - |
| 503 | GRDX | GridAI Technologies Corp. | 15.67M | 12.83% | 309,642 | - |
| 504 | GDTC | CytoMed Therapeutics Limited | 15.41M | -5.32% | 97,254 | 573.19K |
| 505 | HOTH | Hoth Therapeutics, Inc. | 15.36M | -1.00% | 199,285 | - |
| 506 | LEXX | Lexaria Bioscience Corp. | 15.36M | 13.46% | 700,694 | 705.92K |
| 507 | NCNA | NuCana plc | 14.98M | 1.98% | 53,579 | - |
| 508 | FBLG | FibroBiologics, Inc. | 14.96M | -7.03% | 21,653,724 | - |
| 509 | KAPA | Kairos Pharma, Ltd. | 14.78M | 1.46% | 103,538 | - |
| 510 | PMN | ProMIS Neurosciences, Inc. | 14.69M | -2.36% | 29,037 | - |
| 511 | OSRH | OSR Holdings, Inc. | 14.48M | -2.22% | 348,943 | -90.52K |
| 512 | APLT | Applied Therapeutics, Inc. | 14.43M | 2.99% | 8,094,817 | 1.00M |
| 513 | ASBP | Aspire Biopharma Holdings, Inc. | 14.18M | -7.11% | 13,924,129 | 1.94K |
| 514 | TPST | Tempest Therapeutics, Inc. | 14.14M | 1.06% | 100,815 | - |
| 515 | SNGX | Soligenix, Inc. | 13.52M | 0.75% | 264,177 | 2.34K |
| 516 | COCP | Cocrystal Pharma, Inc. | 13.49M | 3.19% | 145,999 | - |
| 517 | BCTX | BriaCell Therapeutics Corp. | 13.47M | -6.32% | 78,087 | - |
| 518 | SNSE | Sensei Biotherapeutics, Inc. | 13.46M | 20.56% | 201,395 | - |
| 519 | BCDA | BioCardia, Inc. | 13.27M | 5.93% | 161,322 | 3.00K |
| 520 | AKTX | Akari Therapeutics, Plc | 13.23M | 8.04% | 836,283 | - |
| 521 | SYBX | Synlogic, Inc. | 13.10M | -0.88% | 32,901 | 8.00K |
| 522 | AEON | AEON Biopharma, Inc. | 13.02M | 1.85% | 534,156 | - |
| 523 | CRIS | Curis, Inc. | 12.76M | -2.27% | 166,934 | 11.65M |
| 524 | CLRB | Cellectar Biosciences, Inc. | 12.51M | 5.11% | 61,953 | - |
| 525 | BLRX | BioLineRx Ltd. | 12.29M | -3.48% | 32,210 | 12.74M |
| 526 | QNRX | Quoin Pharmaceuticals, Ltd. | 12.11M | 6.89% | 44,567 | - |
| 527 | EDSA | Edesa Biotech, Inc. | 11.83M | -5.96% | 80,896 | - |
| 528 | IMNN | Imunon, Inc. | 11.70M | 9.48% | 99,971 | - |
| 529 | ABP | Abpro Holdings, Inc. | 11.49M | 2.42% | 6,558 | 183.00K |
| 530 | PHIO | Phio Pharmaceuticals Corp. | 11.30M | 2.94% | 300,798 | - |
| 531 | INAB | IN8bio, Inc. | 10.84M | 0.43% | 110,425 | - |
| 532 | LGVN | Longeveron Inc. | 10.79M | 0.58% | 316,111 | 1.44M |
| 533 | BOLT | Bolt Biotherapeutics, Inc. | 10.50M | 3.17% | 25,495 | 5.20M |
| 534 | BRTX | BioRestorative Therapies, Inc. | 10.43M | 0.86% | 37,432 | 383.40K |
| 535 | MBRX | Moleculin Biotech, Inc. | 10.20M | -0.30% | 102,339 | - |
| 536 | CMMB | Chemomab Therapeutics Ltd. | 10.16M | 0.61% | 110,554 | - |
| 537 | ERNA | Ernexa Therapeutics Inc. | 9.42M | 2.56% | 46,879 | 1,000.00 |
| 538 | EVGN | Evogene Ltd. | 9.15M | 17.07% | 182,779 | 8.02M |
| 539 | TRAW | Traws Pharma, Inc. | 9.03M | 3.67% | 92,560 | 2.85M |
| 540 | APVO | Aptevo Therapeutics Inc. | 8.83M | 0.43% | 193,330 | - |
| 541 | BIVI | BioVie Inc. | 8.74M | 2.65% | 121,849 | - |
| 542 | NCEL | NewcelX Ltd. | 8.66M | -6.40% | 43,480 | - |
| 543 | ICU | SeaStar Medical Holding Corporation | 8.65M | 5.26% | 678,104 | 881.00K |
| 544 | APM | Aptorum Group Limited | 8.63M | -4.50% | 41,895 | - |
| 545 | CLDI | Calidi Biotherapeutics, Inc. | 8.56M | 1.74% | 130,228 | - |
| 546 | GTBP | GT Biopharma, Inc. | 8.35M | -3.53% | 1,683,460 | - |
| 547 | ADXN | Addex Therapeutics Ltd | 8.17M | -0.26% | 315 | 198.82K |
| 548 | PULM | Pulmatrix, Inc. | 8.14M | 2.29% | 30,628 | 3.00K |
| 549 | IMRN | Immuron Limited | 7.82M | 1.53% | 84,959 | 4.78M |
| 550 | PMCB | PharmaCyte Biotech, Inc. | 7.34M | 0.56% | 292,543 | - |
| 551 | BGMS | Bio Green Med Solution, Inc. | 7.25M | -5.13% | 53,333 | 81.00K |
| 552 | CELZ | Creative Medical Technology Holdings, Inc. | 7.25M | 6.52% | 138,769 | 6.00K |
| 553 | KPRX | Kiora Pharmaceuticals, Inc. | 7.23M | 1.55% | 33,276 | 20.00K |
| 554 | TCRT | Alaunos Therapeutics, Inc. | 7.21M | -4.15% | 54,055 | 6.00K |
| 555 | PPCB | Propanc Biopharma, Inc. | 7.17M | -7.48% | 157,950 | - |
| 556 | MBIO | Mustang Bio, Inc. | 7.16M | 3.26% | 160,625 | - |
| 557 | TOVX | Theriva Biologics, Inc. | 7.10M | 7.35% | 8,882,707 | - |
| 558 | PPBT | Purple Biotech Ltd | 7.00M | 1.36% | 94,371 | - |
| 559 | ALZN | Alzamend Neuro, Inc. | 6.92M | -5.21% | 187,851 | - |
| 560 | XTLB | XTL Biopharmaceuticals Ltd. | 6.64M | -16.55% | 101,080 | 968.00K |
| 561 | PCSA | Processa Pharmaceuticals, Inc. | 6.53M | -1.71% | 135,827 | - |
| 562 | RNAZ | TransCode Therapeutics, Inc. | 6.26M | 6.06% | 60,370 | - |
| 563 | SLXN | Silexion Therapeutics Corp | 6.00M | 10.98% | 121,478 | - |
| 564 | KALA | KALA BIO, Inc. | 5.96M | -1.82% | 669,108 | - |
| 565 | ADIL | Adial Pharmaceuticals, Inc. | 5.86M | -3.76% | 339,848 | - |
| 566 | LYRA | Lyra Therapeutics, Inc. | 5.47M | -3.75% | 27,335 | 600.00K |
| 567 | APRE | Aprea Therapeutics, Inc. | 5.38M | -4.16% | 153,427 | 488.24K |
| 568 | ACXP | Acurx Pharmaceuticals, Inc. | 5.19M | -4.96% | 64,580 | - |
| 569 | INDP | Indaptus Therapeutics, Inc. | 5.10M | 6.99% | 330,048 | - |
| 570 | GOVX | GeoVax Labs, Inc. | 5.08M | -0.52% | 1,449,641 | 3.35M |
| 571 | XBIO | Xenetic Biosciences, Inc. | 4.97M | 4.33% | 18,498 | 2.86M |
| 572 | CDIO | Cardio Diagnostics Holdings, Inc. | 4.95M | -14.78% | 54,127 | 15.78K |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 4.83M | 7.63% | 30,544 | 2.86M |
| 574 | REVB | Revelation Biosciences, Inc. | 4.74M | -3.90% | 177,674 | - |
| 575 | VIVS | VivoSim Labs, Inc. | 4.72M | -0.55% | 56,677 | 140.00K |
| 576 | SILO | Silo Pharma, Inc. | 4.53M | -2.86% | 256,543 | 72.10K |
| 577 | SPRC | SciSparc Ltd. | 4.46M | 0.74% | 277,188 | 1.31M |
| 578 | JAGX | Jaguar Health, Inc. | 4.22M | -6.05% | 178,645 | 11.79M |
| 579 | GLMD | Galmed Pharmaceuticals Ltd. | 4.11M | -0.38% | 87,383 | - |
| 580 | GNPX | Genprex, Inc. | 4.06M | -0.57% | 187,054 | - |
| 581 | XRTX | XORTX Therapeutics Inc. | 3.92M | 0.36% | 39,064 | - |
| 582 | SLRX | Salarius Pharmaceuticals, Inc. | 3.80M | 0.19% | 70,449 | - |
| 583 | MTNB | Matinas BioPharma Holdings, Inc. | 3.75M | 0.17% | 56,369 | - |
| 584 | ENVB | Enveric Biosciences, Inc. | 3.71M | -7.16% | 44,895 | - |
| 585 | ENSC | Ensysce Biosciences, Inc. | 3.34M | -0.55% | 161,136 | 4.49M |
| 586 | OGEN | Oragenics, Inc. | 3.26M | 3.82% | 53,606 | - |
| 587 | CNSP | CNS Pharmaceuticals, Inc. | 3.26M | -3.85% | 16,387 | - |
| 588 | PHGE | BiomX Inc. | 2.85M | 0.54% | 38,110 | - |
| 589 | AZTR | Azitra, Inc. | 2.84M | -3.36% | 355,712 | 7.50K |
| 590 | CMND | Clearmind Medicine Inc. | 2.71M | -2.69% | 114,347 | - |
| 591 | HCWB | HCW Biologics Inc. | 2.62M | -14.41% | 274,405 | 422.03K |
| 592 | PTIX | Protagenic Therapeutics, Inc. | 2.52M | -4.41% | 74,169 | - |
| 593 | GRI | GRI Bio, Inc. | 2.50M | -11.29% | 4,405,808 | - |
| 594 | ARTL | Artelo Biosciences, Inc. | 2.46M | 5.17% | 51,207 | - |
| 595 | ONCO | Onconetix, Inc. | 2.43M | 9.09% | 148,139 | 1.22M |
| 596 | DRMA | Dermata Therapeutics, Inc. | 2.38M | 1.75% | 681,086 | - |
| 597 | SCNI | Scinai Immunotherapeutics Ltd. | 2.27M | -0.67% | 33,002 | 1.15M |
| 598 | VRAX | Virax Biolabs Group Limited | 2.26M | -0.86% | 4,224,487 | 2.99K |
| 599 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.15M | 0.53% | 679,688 | 1.36M |
| 600 | CDT | CDT Equity Inc. | 2.09M | -2.29% | 48,111 | - |
| 601 | BDRX | Biodexa Pharmaceuticals Plc | 1.55M | -1.30% | 76,721 | 104.90K |
| 602 | ADTX | Aditxt, Inc. | 1.48M | -8.48% | 314,153 | 5.95K |
| 603 | PBM | Psyence Biomedical Ltd. | 1.41M | -5.36% | 555,454 | - |
| 604 | ELAB | PMGC Holdings Inc. | 1.10M | - | 661,780 | 285.95K |
| 605 | MLEC | Moolec Science SA | 1.02M | -4.18% | 2,002,750 | 7.83M |